ENERTIVA
RETATUTIDE 60mg / 3mL
Product details are available publicly. Please log in to view pricing and place an order.
Login to View PriceTesting & COA
View History- Tirzepatide is a dual incretin receptoragonist targeting both glucose-dependentinsulinotropic polypeptide (GIP) andglucagon-like peptide-1 (GLP-1) pathways.
- By simultaneously activating thesemetabolic signaling systems, it supportsenhanced glycemic control, appetiteregulation, and energy balance.
- This dual-mechanism approachdistinguishes tirzepatide from traditionalsingle-pathway GLP-1 therapies, offering abroader metabolic impact. It plays a rolein improving insulin sensitivity,modulating gastric emptying, andinfluencing satiety signaling, making ithighly relevant in metabolic-focused protocols.
- Manufactured under controlled, high-purity standards, tirzepatide is designedfor consistency and stability acrossbatches. Its defined structure andreproducibility support clinicalenvironments and structured metabolicprograms where precision and reliabilityare essential.
